First, a bit of context: when your cells make proteins, the ribosome read a sequence from mRNA in the form of three-letter codes (called codons). There are 64 possible codons which specify 20 amino acids or a STOP sequence to indicate the end of the protein.
Because the codons are read 3 letters at a time, it is possible to start reading them in the wrong spot (either 1 or 2 letters over) and end up with a protein that is completely different from the one you intended because this will change the amino acid downstream because...
the codons will now be completely different. If this occurs it is known as a frameshift (note: if a frameshift occurs 3 bases over, then this doesn't happen because the reading frame won't be affected, but you may duplicate or lose 1 amino acid).
In general, frameshifts are not what you want as an outcome of protein production- but not always. Frameshifts are uncommon but naturally occurring events in, for example, viral infections. These give rise to protein products that can also be targeted by the immune system.
For example, it was recently shown that influenza can produce a unique protein product through a frameshift that is very strongly recognized by killer T cells:
This resulting frameshifted product might have an important role in protection from flu.nature.com/articles/s4159…
Coronaviruses have evolved to require frameshifting as part of their replication cycle to make their proteins:
Anyway, let’s get back to this paper. mRNA vaccines are made with replacement of all of the U’s in the sequence of interest with m1ψ.jbc.org/article/S0021-…
This modification naturally occurs in our own ribosomal RNA. RNA has to be modified to prevent triggering of an antiviral immune response that would suppress production of the encoded protein (which would then prevent an effective antibody response):
Prior work has shown that this results in faithful production of the protein product of interest (spike):
This is a really important point not to lose sight of: the mRNA vaccines are excellent at making the thing we want them to make.ncbi.nlm.nih.gov/pmc/articles/P…
This work argues however that this modification promotes frameshifting. Let’s take a look. First, the authors used a sample mRNA sequence that was designed to produce the end of the enzyme luciferase, which is what enables fireflies to glow.
If the Fluc+1FS RNA were made without frameshift mutations, then there wouldn’t be detectable luciferase activity from the frameshifted product. Here we can see that the m1ψ produced luciferase has the frameshifted product as evident by activity of the luciferase.
On the western blot examining the protein product resulting from different RNA modifications, while there are 2 additional bands for the m1ψ mRNA, it is noteworthy that there is faithful production of the in-frame product as well.
This broadly agrees with work from 2015 that showed that there is markedly enhanced protein production from m1ψ RNA.
This is, fundamentally, the point of using the modification: you want faithful production of your protein inside actual cells.sciencedirect.com/science/articl…
The authors however took it a step further, wondering whether the frameshifting was actually happening in real life. They vaccinated mice with the Pfizer or Oxford/AZ vaccine and looked for evidence of T cell responses against out-of-frame peptides, and…
the mice that received the Pfizer vaccine did show responses against the out-of-frame peptides (2b). But: they also had greater T cell responses to the in-frame peptides (2c) than those that received Oxford/AZ vaccine.
When they looked in humans, they found that the recipients of the Pfizer vaccine also had responses against out-of-frame peptides, but this varied a lot across individuals, suggesting that the extent of frameshifting may also vary a lot between individuals. Note: 2e is mouse data
Anyway, from here, the authors go on to identify “slippery” sites in mRNA that are prone to frameshifting, and they also show that the antibiotic paromomycin (which interferes with decoding of codons by the ribosome) promotes the fidelity of translation with the modified RNA.
The authors show that modification of these sequences to get rid of slippery sites seems to reduce frameshifting events. So, what’s the significance of these results?
In a practical sense as far as it applies to vaccination, IMO not much.
The sequences of Pfizer and Moderna differ significantly at the nucleotide level, but the nature of the responses and their safety profile is broadly similar, arguing against frameshift products in either case having a meaningful effect.
I do think that the major use of these findings is that they highlight the importance of understanding how immune responses against frameshifted peptides affect protection in the case of infection.
The major reason this would be relevant is because it adds a second dimension to codon optimization (because codons are redundant for any given amino acid, you can choose the “best” one for your particular application) in that...
one might want to optimize in such a way that it preserves major frameshifted peptides that may be important for immune responses.
Still, frameshifting within spike protein is not known to date to result in peptides of special importance to the immune response, so...
it’s not likely that it matters much here either way. The authors are (correctly) explicit here that there is no evidence of this contributing to any kind of safety issues with the mRNA vaccines.
Some clueless people claim that this somehow means there's a heightened...
risk of autoimmune disease because of these frameshifted products. For this to be true, there would need to be meaningful production of products that closely resemble our own proteins- something there. is no evidence for.
We in fact see that in stark contrast to COVID-19, there is no autoimmune signature for mRNA vaccines:
So, basically: a useful study but not good cause to worry about mRNA vaccines.nature.com/articles/s4146…
I realized I should perhaps include another point of clarification to help people understand the significance of this issue.
Within cells, any given mRNA is translated by many ribosomes (not just one). mRNA can form assembles of ribosomes called polysomes or polyribosomes:
m1ψ mRNA is particularly good at forming polysomes:
This helps to explain why the yield of proteins from mRNA bearing this modification is so much higher. The significance of this is simply that your cells have a ton of opportunities to make...ncbi.nlm.nih.gov/pmc/articles/P…
the correct protein from any given mRNA. If one ribosome frameshifts, it does not mean *every* ribosome will frameshift. Remember: the frameshifted product was a minor fraction of the overall proteins.
People should also take note that questions about the safety of mRNA vaccines have been repeatedly asked and answered. Data on billions of doses across the last few years affirms their excellent safety profile (reactogenicity notwithstanding). This requires no knowledge...
of cellular and molecular mechanisms. We eradicated smallpox with a vaccine that essentially pre-dates any modern understanding of the immune system. Despite the sexiness of the mechanisms, pharmacoepidemiology is and should always be king of safety evaluations.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
The idea is simple enough: 155 adults aged 50-70 who received 2 priming doses of Oxford/AZ's COVID-19 vaccine (adenovirus vector) and a licensed booster 3 months before enrollment were randomized to receive a dose of Pfizer, Moderna, or Novavax's vaccines.
People seem to be taking away from this study that Novavax's vaccine somehow gave an immune response that was better than either mRNA vaccine, which is... an odd take. The paper emphasizes that the antibody titer with Novavax was more sustained. This is true, however...
New paper in Cell describes an antibody from Vir that seems to have potent activity against a number of coronaviruses, some of which do not even use ACE2:
First though I want to spend a minute talking about where this antibody came from, because this aspect of things tends to be underappreciated. Before there was Vir-7229, there was S2V29, a candidate antibody that covered all SARS-like coronaviruses:
S2V29 came from a participant who had been vaccinated against and infected with SARS-CoV-2. From there, S2V29 underwent affinity maturation using SARS-CoV-1, SARS-CoV-2, and BQ.1.1 variant RBDs via yeast display. These were then screened and revealed an antibody that had...
3/10
It was preprinted a while ago but since that time I have had an opportunity to talk to some plasma cells researchers and it is apparent that there is a lot of important nuance being missed 🧵nature.com/articles/s4159…
Background: antibodies against the spike protein are protective against infection by SARS-CoV-2. Antibodies are made by antibody-secreting cells (ASCs) which come from B cells and vary widely in their lifespan. The goal of vaccination is generally to elicit durable antibodies.
Long-lived plasma cells (LLPCs) are ASCs that can live for many years (potentially your lifetime). They are canonically found within the bone marrow, but mucosal LLPCs have also been described. The problem: there is no simple way to define look at a cell and say it's an LLPC.
Seeing people talk about this case report recently... Some are framing this as evidence that SARS-CoV-2 *routinely* causes devastating neurological disease, which isn't true and is ultimately not an honest interpretation of the data therein. 🧵
IMO it is very hard to conclude anything about the general behavior of SARS-CoV-2 with regard to the brain from this case report, especially as it applies to today. For one, this case report describes an infection that happened in 2020- but this a relatively minor detail...
compared with this part: the patient in question had HIV (was not aware of it), had a massive viral load, and a CD4 T cell count that is known to produce every AIDS-defining condition seen in PLWHIV. One of these conditions is progressive multifocal leukoencephalopathy (PML).
Aaron Siri is misrepresenting a perspective piece in NEJM authored by Daniel A. Salmon, Walter A. Orenstein, Stanley A. Plotkin, and Robert T. Chen concerning vaccine safety studies. You can read the perspective via these screenshots (it's paywalled). Some comments from me 🧵:
The gist of the perspective is that vaccine safety studies take a lot of time. The US currently has a means to compensate those harmed by vaccines via the NVICP, and the budget for the NVICP comes from an excise tax on vaccines, and it has a large surplus at the moment.
Therefore, it would make sense to divert at least some of that funding to research harms from vaccines that can be used to better understand them. A major concern here is the lack of efficient funding delays this work. It does not at any point argue that vaccines are unsafe.
One thing on my mind more in recent times is the way that we've managed to make health, and in particular public health, feel normative- and in some ways that's a double-edged sword.
Undeniably, it's far more positive than it is negative.
If someone drinks milk and gets paralyzed from Guillain-Barre syndrome today, that is a shocking event.
If someone takes a medication and develops lead poisoning from it being tainted, that is a shocking event.
If someone develops radiation poisoning from their drinking water, that is a shocking event.
If there's a cholera outbreak in a metropolitan area, that is a shocking event.
Today, all of these things lie far outside the bounds of what is ordinary in the US.